Ignite Creation Date:
2024-05-05 @ 11:43 AM
Last Modification Date:
2024-10-26 @ 9:12 AM
Study NCT ID:
NCT00117182
Status:
COMPLETED
Last Update Posted:
2016-04-20
First Post:
2005-06-30
Brief Title:
Aridol Challenge as a Tool to Predict Treatment Response to Inhaled Corticosteroids in COPD
Sponsor:
Syntara
Organization:
Syntara
Study Overview
Official Title:
A Phase II Study to Investigate Mannitol Challenge as a Tool to Predict Treatment Response to Inhaled Corticosteroids in COPD
Status:
COMPLETED
Status Verified Date:
2016-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to determine whether the Aridol mannitol challenge test can predict response to treatment with inhaled corticosteroids in COPD subjects Subjects will undergo an Aridol test and then 3 months of treatment with inhaled corticosteroids The effect on lung function and quality of life will then be measured and correlated with the Aridol test result
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None